Search
Close this search box.

More Sickened After Eating Diamond Shruumz Bars, Cones and Gummies – Drugs.com MedNews

Medically reviewed by Drugs.com.

By Ernie Mundell HealthDay Reporter

WEDNESDAY, June 12, 2024 — The number of people severely sickened after consuming mushroom edibles sold as Diamond Shruumz-brand Chocolate Bars, Cones or Gummies has risen, the U.S. Food and Drug Administration said Tuesday.

As of Monday, “a total of 12 illnesses have been reported from eight states,” the FDA noted in an updated advisory. “All 12 people have reported seeking medical care; 10 have been hospitalized.” No deaths have been reported.

Symptoms have included “seizures, central nervous system depression [loss of consciousness, confusion, sleepiness], agitation, abnormal heart rates, hyper/hypotension, nausea and vomiting,” the agency added.

The Diamond Shruumz-brand mushroom edible products are being marketed online and at smoke/vape shops, legal CBD/THC shops and other retail outlets nationwide. The FDA is asking retailers to stop selling the products.

The edibles pose a special danger to kids, the agency added.

“This product may appeal to children and teenagers as it is marketed as a candy,” the FDA noted. “Parents and caregivers should consider discussing the information in this advisory with their children and take extra care to avoid this product being consumed by younger people.”

Anyone who does become ill after consuming Diamond Shruumz-brand products should call the Poison Help Line at 800-222-1222 and let them know the product was consumed.

Sources

  • U.S. Food and Drug Administration, news releases, June 7 and 11, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.